Kamada (KMDA) Dividends Paid - Common Growth (3y) (2016 - 2026)
Kamada (KMDA) Dividends Paid - Common Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 8.83% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 0.43% |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -0.96% |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Kamada | 464.34 Mn | 434.87 Mn | 22.47 Mn | -12.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -12.85% |
| Mar 31, 2026 | 966.74% |
| Sep 30, 2025 | 1,220.72% |
| Jun 30, 2025 | -33.61% |
| Mar 31, 2025 | 51.41% |
| Dec 31, 2024 | 27.64% |
| Sep 30, 2024 | -10.32% |
| Jun 30, 2024 | -6.15% |
| Dec 31, 2023 | -44.44% |
| Sep 30, 2023 | 0.07% |
| Jun 30, 2023 | -27.59% |
| Dec 31, 2022 | 31.03% |
| Sep 30, 2022 | -89.56% |
| Jun 30, 2022 | 7.89% |
| Dec 31, 2021 | -48.70% |
| Sep 30, 2021 | 97.95% |
| Jun 30, 2021 | 76.91% |
| Sep 30, 2020 | 62.84% |
| Jun 30, 2020 | 73.32% |
| Sep 30, 2019 | 61.84% |